These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24013771)

  • 1. From immunosuppression to immunomodulation: current principles and future strategies.
    Kovarik J
    Pathobiology; 2013; 80(6):275-81. PubMed ID: 24013771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in transplantation.
    Levy GA
    Ther Drug Monit; 2010 Jun; 32(3):246-9. PubMed ID: 20418803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction therapy: why, when, and which agent?
    Krischock L; Marks SD
    Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression in organ transplantation.
    Jordan SC; Rosenthal P; Makowka L
    Semin Pediatr Surg; 1993 Nov; 2(4):206-7. PubMed ID: 8062042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation.
    Campa-Carranza JN; Paez-Mayorga J; Chua CYX; Nichols JE; Grattoni A
    Expert Opin Drug Deliv; 2022 May; 19(5):595-610. PubMed ID: 35588058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progression factors in chronic kidney disease. Immunological mechanisms].
    Capdevila Plaza L; Cubero JJ; Luna E; Hernández Gallego R
    Nefrologia; 2009; 29 Suppl 1():7-15. PubMed ID: 19675656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in immunosuppression for lung transplantation.
    Floreth T; Bhorade SM
    Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consideration of strategies for hematopoietic cell transplantation.
    Yaniv I; Ash S; Farkas DL; Askenasy N; Stein J
    J Autoimmun; 2009; 33(3-4):255-9. PubMed ID: 19800763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive drugs.
    Bowman H; Lennard TW
    Br J Hosp Med; 1992 Nov 4-17; 48(9):570-3, 576-9. PubMed ID: 1282440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation for autoimmune disorders: evolution of therapeutics.
    Liebman HA
    Semin Hematol; 2016 Apr; 53 Suppl 1():S23-6. PubMed ID: 27312159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney.
    Sandovici M; Deelman LE; Benigni A; Henning RH
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1358-68. PubMed ID: 20688115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation].
    Infante B; Stallone G; Schena A; Maiorano A; Gesualdo L; Schena FP; Grandaliano G
    G Ital Nefrol; 2006; 23(4):389-95. PubMed ID: 17063439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New immunosuppressive strategies and the risk of infection.
    Mueller NJ
    Transpl Infect Dis; 2008 Dec; 10(6):379-84. PubMed ID: 18811628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrology--Part 2. Strategies in the immunosuppression after kidney transplantation].
    Sperschneider H; Heemann U; Stein G
    Med Klin (Munich); 2003 Mar; 98(3):140-5. PubMed ID: 12647088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.
    Vianna R
    Minerva Pediatr; 2009 Jun; 61(3):293-303. PubMed ID: 19461573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.